United States Gastrointestinal Devices Market Overview 2016-2017 - Research and Markets

DUBLIN, November 3, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "US Market Overview for Gastrointestinal Devices 2017 - MedView" report to their offering.

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret's Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options.

The U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret's Esophagus. The largest segment in the total GI endoscopic device market was the GI flexible endoscope segment.

This segment represented approximately 24.5% of the total market in 2016. The relatively large size of this segment is due to a combination of relatively high average selling price (ASP) coupled with relatively short life-span of five years, resulting in constant renewal of the equipment. One of the main drivers in this market is the growth in the procedure numbers, such as colonoscopy and therapeutic ERCP. Colonoscopy has become a gold-standard in the colorectal cancer screening program, with more than 18 million procedures performed annually. A lot of devices discussed in this report are used in conjunction with the each other, thus having a multiplication effect on the size of the market with each extra procedure performed.

Key Topics Covered:

1. U.S. Gastrointestinal Endoscopic Device Market Overview Competitive Analysis Market Trends Market Developments Procedure Numbers Procedure Codes Investigated Markets Included

1.1 Key Report Updates Version History Research Methodology

2. Disease Overview

2.1 Basic Anatomy

2.2 Gastrointestinal Disease: Treatment And Diagnostics

2.2.1 Gastro-Esophageal Reflux Disease (GERD)

2.2.2 Barrett's Esophagus

2.2.3 Digestive Cancer

2.2.4 Gastrointestinal Bleeding

2.2.5 Bile Duct Disorders

2.2.6 Crohn's Disease

2.2.7 Ulcer

2.2.8 Ogilvie Syndrome Or Intestinal Pseudo-Obstruction

2.3 Patient Demographics

2.3.11 Patient Demographics

2.3.11.1 All Digestive Diseases

2.3.11.2 Abdominal Wall Hernia

2.3.11.3 Chronic Constipation

2.3.11.4 Diverticular Disease

2.3.11.5 Prescriptions

2.3.11.6 Gastroesophageal Reflux Disease

2.3.11.7 Gastrointestinal Infections

2.3.11.8 Hemorrhoids

2.3.11.9 Inflammatory Bowel Disease

2.3.11.10 Liver Disease

2.3.11.11 Pancreatitis

2.3.11.12 Peptic Ulcer Diseases

2.3.12 Digestive Cancer

3. U.S. Gastrointestinal Endoscopic Device Market Overview

3.1 Market Overview

3.2 Trend Analysis

3.3 Drivers And Limiters

3.3.1 Market Drivers

3.3.2 Market Limiters

3.4 Competitive Market Share Analysis

3.5 Company Profiles

3.5.1 Boston Scientific Corporation

3.5.2 Olympus

3.5.3 Medtronic

3.5.4 Cook Medical

3.5.5 Halyard Health

3.5.6 Hoya Group Pentax Medical

3.5.7 Fujifilm Holdings Corporation

3.5.8 Us Endoscopy

3.5.9 Conmed Corporation

3.5.10 C. R. Bard

3.5.11 Erbe Usa Inc.

3.5.12 Endogastric Solutions

3.5.13 General Electric

3.6 Swot Analysis

3.6.1 Boston Scientific

3.6.2 Olympus

3.6.3 Medtronic

3.6.4 Cook Medical

3.6.5 Halyard

3.7 Mergers And Acquisitions

3.7.1 Olympus

3.7.2 Boston Scientific Corporation

3.7.3 Medtronic

3.7.4 Hoya Group Pentax Medical

3.7.5 Fujifilm Holdings Corporation

3.7.7 Abbott Nutrition

3.7.8 Us Endoscopy

3.7.10 Conmed Corporation

3.7.12 Halyard Health

3.7.14 Ethicon, Johnson & Johnson And Others

3.7.16 Medivators, A Cantel Medical Company

3.7.17 Endochoice Holdings, Inc.

3.7.18 Vital Images And Toshiba

For more information about this report visit http://www.researchandmarkets.com/research/mkhg7v/us_market

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[e-mail]

For E.S.T Office Hours Call [phone]

For U.S./CAN Toll Free Call [phone]

For GMT Office Hours Call [phone]

U.S. Fax: [phone]

Fax (outside U.S.): [phone]